On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

RSV causes 42K hospitalizations annually in adults ... Minter highlights the Phase 3 trial of mRNA-1345 in over 1,000 high-risk individuals between ages 18 and 59. mRNA-1345 demonstrated non ...

Discover magnetic bead technology for efficient and reliable viral nucleic acid isolation in clinical applications.

The good news is that most cases of whooping cough are preventable with DTaP vaccines in childhood and Tdap shots at age 11 ...

In rare cases, the virus can be contracted from a bite or scratch. The CDC started tracing cases of hantavirus-related ...

As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they ...

The liter-class superbike segment in America has just gotten hotter than ever, all thanks to Aprilia. The Noale factory has ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.